Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 30, 2018 16:40 ET | Source: Forward Pharma A/S

Forward Pharma Reports Full-Year 2017 Financial and Operational Results

COPENHAGEN, Denmark, April 30, 2018 (GLOBE NEWSWIRE) -- Forward Pharma A/S (Nasdaq:FWP) (“We” or “Forward” or the “Company”), today reported financial results for the year ended December 31, 2017....
February 07, 2018 07:30 ET | Source: Forward Pharma A/S

Forward Pharma to Present at the 7th Annual Leerink Partners Global Healthcare Conference

COPENHAGEN, Denmark, Feb. 07, 2018 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (the “Company”) today announced that Dr. Claus Bo Svendsen, the Company’s Chief Executive Officer, will give a...
January 29, 2018 10:44 ET | Source: Forward Pharma A/S

Forward Pharma Announces the Decision of the European Patent Office in the Opposition Proceedings for the EP2801355 Patent

COPENHAGEN, Denmark, Jan. 29, 2018 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“Forward” or the “Company”) today announced that the European Patent Office (the “EPO”) has revoked the...
December 21, 2017 17:00 ET | Source: Forward Pharma A/S

Forward Pharma Files Final Brief in its Appeal of the U.S. Patent Interference to the Federal Circuit

COPENHAGEN, Denmark, Dec. 21, 2017 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“Forward” or the “Company”) today announced the filing of its reply brief to the U.S. Court of Appeals for the...
November 29, 2017 16:30 ET | Source: Forward Pharma A/S

Forward Pharma Files Further Written Submissions in the European Opposition Proceeding for the EP2801355 Patent in Preparation for the Oral Hearing in January 2018

COPENHAGEN, Denmark, Nov. 29, 2017 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“Forward” or the “Company”) today announced the filing of further written submissions in the European...
November 27, 2017 07:30 ET | Source: Forward Pharma A/S

Forward Pharma to Participate in Investor Conferences in December

COPENHAGEN, Denmark, Nov. 27, 2017 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (the “Company”) today announced that Dr. Claus Bo Svendsen, the Company’s Chief Executive Officer, will...
November 22, 2017 16:30 ET | Source: Forward Pharma A/S

Forward Pharma Announces Completion of Corporate Restructuring Plan

COPENHAGEN, Denmark, Nov. 22, 2017 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“Forward Pharma”) today announced the completion of its previously announced corporate restructuring plan (the...
November 09, 2017 16:30 ET | Source: Forward Pharma A/S

Forward Pharma to Participate in the Nordic-American Life Science Conference

COPENHAGEN, Denmark, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (the “Company”) today announced that Dr. Claus Bo Svendsen, the Company’s Chief Executive Officer, will...
September 26, 2017 16:15 ET | Source: Forward Pharma A/S

Forward Pharma Reports Financial and Operational Results from the First Six Months of 2017

COPENHAGEN, Denmark, Sept. 26, 2017 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“We” or “Forward” or the “Company”), today reported financial results for the six-month period ended June 30,...
September 05, 2017 17:00 ET | Source: Forward Pharma A/S

Forward Pharma Files Opening Brief in the Appeal of the U.S. Patent Interference to the Federal Circuit

COPENHAGEN, Denmark, Sept. 05, 2017 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“Forward” or the “Company”) today announced the filing in the U.S. Court of Appeals for the Federal Circuit...